Focused on accelerating the development of new medicines
Translating the potential of a plant-based production system to develop new biological medicines to meet high unmet patient needs worldwide.
Seeking opportunities to accelerate the development of treatments for rare and infectious diseases
KBio is focused on realizing the potential of its existing and future antibody and vaccine clinical pipeline in rare and infectious diseases and will also seek opportunities to form innovative R&D collaborations and financing, with the aim of expanding its pipeline of potential new medicines